This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir Phosphate 75 mg capsules, a generic antiviral medication used to treat influenza. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,121.23 and a completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Oseltamivir Phosphate 75 mg capsules, a medication used to treat and prevent influenza, with a ceiling value of $50,852.35 and a performance period ending on January 23, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir Phosphate 75 mg capsules, a medication used for influenza treatment and prevention. The delivery order has a ceiling value of $2,716.60 and runs through January 6, 2025. The contract is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Oseltamivir Phosphate 75 mg capsules, a medication used to treat influenza. The firm-fixed-price contract has a ceiling value of $2,159.40 and an ultimate completion date of March 7, 2025. The contract is not designated as a set-aside and represents a discrete procurement under a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,987.17 firm fixed-price delivery order is for the purchase of 4,567,104,683 units of Oseltamivir Phosphate 75mg capsules, a medication used to treat influenza. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,800.92, is for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 11, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,465.27, is for the delivery of Oseltamivir Phosphate 75 mg capsules. It is a Firm Fixed Price Delivery Order contract, with a period of performance through February 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Oseltamivir Phosphate 75 mg capsules, a medication used for the treatment of influenza. The contract has a ceiling value of $9,461.04 and a completion date of September 20, 2023. It is a firm-fixed-price delivery order contract, with no set-aside designation....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Oseltamivir Phosphate 75 mg capsules. The contract has a ceiling value of $1,594.56 and a final completion date of February 4, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,545.37, is for the delivery of 4,566,476,996 units of the drug Oseltamivir Phosphate 75mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of November 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen has a...